1.Alternative Name:ILT3,CD85K
2.Target:LILRB4
3.Source:Human DLK1 was expressed from HEK293 with poly His at the C-terminal
4.Sequence:Met1-Glu259
5.Protein structure:NP_001381868.1hFC
6.Molecular Characterization:TThe protein has a calculated MW of 52kDa.The reducing (R) heterodimer protein migrates as 50-70 kDa due to glycosylation
7.Purity:SDS-PAGE>90%，SEC>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
Note:For research use only .


11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 95%.

12.SEC-HPLC

Determined by SEC-HPLC, the purity of the protein is greater than 90%.

13.ELISA

When Anti-Human LILRB4 Antibody (Clone：52B8) is immobilized at 2μg/mL (100 μL/well), the concentration of Recombinant Human LILRB4 / hFC Protein that produces 50% of the optimal binding response is approximately 100 ng/ml.

14.SPR

Anti-Human LILRB4 Antibody (Clone：52B8)（Cat.No.B21851109）captured on CM5 chip , can bind Recombinant Human LILRB4 / hFC Protein（Cat.No.B21851108）with a KD constant of 8.03E-10 M, determined in a SPR assay .